The company says the COBRA-OS is the ‘world’s smallest’ life-saving aortic occlusion device.
This accolade adds to the success for Front Line with this device, recently achieving CE marking to kick off international expansion beyond North America and acquiring an NSN number to improve NATO country military access to the COBRA-OS.
“Putting patients first through ongoing innovation is how we approach our work, and this is clearly evident in the unique technology behind the COBRA-OS,” said Dr. Asha Parekh, CEO of Front Line. “Being recognised by TIME in this way is a testament to all of our efforts, and we are excited for the future as we identify new innovations and strengthen what we can offer for patients.”
Due to its small size, the company says the COBRA-OS allows for rapid and precise deployment for quick intervention in critical situations, temporising patients and buying time until definitive care can be provided.